This Is MS Multiple Sclerosis Community: Knowledge & Support

I wondered why HarryZ had gone quiet. It looks as if he is now working for the Sunday Mirror.

For non-UK citizens, NHS is the National Health Service - the health system in the UK which is funded by taxation and is free at the point of delivery.


http://c.moreover.com/click/here.pl?j623481147&w=464753

Are you sure it is Harry or just someone brave enough to post the truth about the ABC's ?

gwa

GWA,

I always forget to put a smiley face. It's not Harry but the story fits with what Harry and I think.

Ian

Ian,

Ditto

gwa

Actually they're not saying that the interferons don't work (although we know their efficacy is hardly stellar). The point of the article is that up to 40% of patients develop NABs which then limit the efficacy. Currently the presence of NABs is not monitored and it should be.

Interestingly enough there is a new major study going on to assess the effects of NABs on interferon treatment. The kicker is that the study is being funded by Teva who don't produce an interferon but produce Copaxone.

More about commercial interests than patient interests methinks....

Robin

_________________
Do not go gentle into that good night. Rage, rage against the dying of the light.

Ian,



Hey, I tried to get a job with the Sunday Mirror but the UK government wouldn't issue me a working visa

Seriously, the efficacy of the CRABs has been questioned for quite some time. One only needs to read Dr. Behan's Pathogenesis of MS from a few years ago to get a larger picture of how poor the cost/benefit situation is for these drugs. But as usual, good marketing and sales trumps science when it comes to the world of drugs, especially those involving MS.

As we all now know, Tysabri's makers are making a strong effort to take a large chunk of the CRAB's market share away. I doubt it will mean much benefit for MS patients but certainly interesting to follow the action on the "battlefields" as the big pharmas line up against one another!

Take care.

Harry